[Form 4] Acuren Corporation Insider Trading Activity

Rhea-AI Filing Summary

Form 4 highlights: Acuren Corp. (TIC) director Dickerson Wright reported the conversion and acquisition of Acuren common shares on 08/04/2025 following the closing of the NV5 Global merger. In exchange for 13,328 NV5 shares and 157,716 vested NV5 RSAs, Mr. Wright received the merger consideration of 1.1523 TIC shares plus $10 cash per NV5 share.

Indirect ownership: Nine family trusts now hold between 480.7k-2.30m shares each, bringing Wright’s indirect beneficial stake to roughly 8.0 million TIC shares. Wright disclaims beneficial ownership beyond his pecuniary interest but exercises voting and investment power as trustee.

Direct ownership: 9,524 restricted stock units were granted on 08/04/2025; they vest one year later and will settle in an equal number of TIC shares. No shares were disposed of.

Post-transaction, Wright’s economic exposure to Acuren materially increases, aligning his interests with shareholders as the combined entity begins trading.

Positive

• ~8 million TIC shares moved under Wright-controlled trusts, increasing insider alignment with shareholders.
• No shares sold; all activity stems from merger conversion, signalling long-term holding intent.

Negative

• None.

Insights

Corporate Governance Analyst

TL;DR: Wright’s family trusts gained ~8 m TIC shares via merger conversion; alignment positive but routine for closing.

The filing documents share issuance tied to the NV5–Acuren merger, not an open-market purchase. Although the absolute number (≈8 m shares plus 9,524 RSUs) seems large, it reflects automatic conversion, so cash outlay is zero and market-signal value is modest. Still, Wright’s enlarged stake strengthens long-term incentive alignment. No dispositions, option exercises, or sales limits downside concern. Impact on float is already embedded in merger terms; therefore, the disclosure is governance-neutral rather than market-moving.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WRIGHT DICKERSON

(Last) (First) (Middle)

C/O ACUREN CORPORATION

14434 MEDICAL COMPLEX DRIVE, SUITE 100

(Street)

TOMBALL TX 77377

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ACUREN CORP [ TIC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/04/2025		A(1)		2,301,994	A	(1)	2,301,994(1)	I	Wright Family Trust dated December 12, 1990(2)
Common Stock	08/04/2025		A(1)		683,701	A	(1)	683,701(1)	I	The Lauren Wright GST Exempt Trust C/U Dickerson Wright 2010 GRAT(2)
Common Stock	08/04/2025		A(1)		944,148	A	(1)	944,148(1)	I	The Lauren Wright GST Exempt Trust C/U Katherine Wright 2010 GRAT(2)
Common Stock	08/04/2025		A(1)		480,702	A	(1)	480,702(1)	I	The Lauren Wright GST Non-Exempt Trust C/U Katherine Wright 2010 GRAT(2)
Common Stock	08/04/2025		A(1)		683,701	A	(1)	683,701(1)	I	The Stephanie Wright GST Exempt Trust C/U Dickerson Wright 2010 GRAT(2)
Common Stock	08/04/2025		A(1)		741,150	A	(1)	741,150(1)	I	The Stephanie Wright GST Non-Exempt Trust C/U Dickerson Wright 2010 GRAT(2)
Common Stock	08/04/2025		A(1)		944,148	A	(1)	944,148(1)	I	The Stephanie Wright GST Exempt Trust C/U Katherine Wright 2010 GRAT(2)
Common Stock	08/04/2025		A(1)		480,702	A	(1)	480,702(1)	I	The Stephanie Wright GST Non-Exempt Trust C/U Katherine Wright 2010 GRAT(2)
Common Stock	08/04/2025		A(1)		741,150	A	(1)	741,150(1)	I	The Lauren Wright GST Non-Exempt Trust C/U Dickerson Wright 2010 GRAT(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(3)	08/04/2025		A		9,524		(4)	(4)	Common Stock	9,524	$0.00	9,524	D

Explanation of Responses:

1. On August 4, 2025, as a result of the mergers contemplated by that certain Agreement and Plan of Merger, dated as of May 14, 2025, by and among the Issuer, NV5 Global, Inc. ("NV5"), Ryder Merger Sub I and Ryder Merger Sub II (the "Merger Agreement"), 13,328 shares of common stock of NV5 and 157,716 restricted stock awards of NV5 (which were vested in full in accordance with their terms immediately prior to the effective time of the mergers and converted into the right to receive the Merger Consideration, less applicable tax withholdings)were converted into the right to receive 1.1523 shares of the Issuer's common stock ("Common Stock") per share, and $10.00 in cash per share, without interest (collectively, the "Merger Consideration"). Pursuant to the Merger Agreement, any outstanding restricted stock award of NV5 held by the Reporting Person automatically vested in full in accordance with its terms immediately prior to the effective time of the mergers.

2. Dickerson Wright and his wife, Katherine Wright, are trustees. As a trustee, the Reporting Person may be deemed to exercise voting and investment power over the shares held by each trust. Mr. Wright disclaims beneficial ownership of these securities except to the extent of this pecuniary interest therein.

3. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

4. These restricted stock units vest on August 4, 2026 (the one-year anniversary of the grant date).

	/s/ MaryJo Obrien, Attorney-in-Fact	08/06/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Acuren (TIC) shares did Dickerson Wright acquire?

Trusts controlled by Wright received about 8.0 million shares; he also received 9,524 RSUs that vest in 2026.

Was cash paid for the newly reported shares?

No. Shares were issued automatically from the NV5 merger conversion with no additional cash outlay by Wright.

What is the vesting schedule for the 9,524 RSUs?

The RSUs vest on 08/04/2026, one year from the grant date.

Does the filing indicate any share sales by the insider?

No. No dispositions were reported; all transactions were coded "A" for acquisition.

Why were NV5 shares converted into Acuren shares?

The conversion terms stem from the May 14 2025 Merger Agreement between Acuren, NV5, and related merger subsidiaries.